1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
2
|
Asamura H, Goya T, Koshiishi Y, Sohara Y,
Eguchi K, Mori M, Nakanishi Y, Tsuchiya R, Shimokata K, Inoue H, et
al: A Japanese lung cancer registry study: Prognosis of 13,010
resected lung cancers. J Thorac Oncol. 3:46–52. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Mountain CF: Revisions in the
international system for staging lung cancer. Chest. 111:1710–1717.
1997. View Article : Google Scholar : PubMed/NCBI
|
4
|
Tsuboi M, Ohira T, Saji H, Miyajima K,
Kajiwara N, Uchida O, Usuda J and Kato H: The present status of
postoperative adjuvant chemotherapy for completely resected
non-small cell lung cancer. Ann Thorac Cardiovasc Surg. 13:73–77.
2007.PubMed/NCBI
|
5
|
Tremblay G: Stromal aspects of breast
carcinoma. Exp Mol Pathol. 31:248–260. 1979. View Article : Google Scholar : PubMed/NCBI
|
6
|
Gabbiani G, Ryan GB and Majne G: Presence
of modified fibroblasts in granulation tissue and their possible
role in wound contraction. Experientia. 27:549–550. 1971.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Rønnov-Jessen L, Petersen OW, Koteliansky
VE and Bissell MJ: The origin of the myofibroblasts in breast
cancer. Recapitulation of tumor environment in culture unravels
diversity and implicates converted fibroblasts and recruited smooth
muscle cells. J Clin Invest. 95:859–873. 1995. View Article : Google Scholar : PubMed/NCBI
|
8
|
Olumi AF, Grossfeld GD, Hayward SW,
Carroll PR, Tlsty TD and Cunha GR: Carcinoma-associated fibroblasts
direct tumor progression of initiated human prostatic epithelium.
Cancer Res. 59:5002–5011. 1999.PubMed/NCBI
|
9
|
Okusa Y, Ichikura T and Mochizuki H:
Prognostic impact of stromal cell-derived urokinase-type
plasminogen activator in gastric carcinoma. Cancer. 85:1033–1038.
1999. View Article : Google Scholar : PubMed/NCBI
|
10
|
Orimo A, Gupta PB, Sgroi DC,
Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL
and Weinberg RA: Stromal fibroblasts present in invasive human
breast carcinomas promote tumor growth and angiogenesis through
elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Hasebe T, Sasaki S, Imoto S and Ochiai A:
Highly proliferative fibroblasts forming fibrotic focus govern
metastasis of invasive ductal carcinoma of the breast. Mod Pathol.
14:325–337. 2001. View Article : Google Scholar : PubMed/NCBI
|
12
|
Forsberg K, Valyi-Nagy I, Heldin CH,
Herlyn M and Westermark B: Platelet-derived growth factor (PDGF) in
oncogenesis: Development of a vascular connective tissue stroma in
xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad
Sci USA. 90:pp. 393–397. 1993; View Article : Google Scholar : PubMed/NCBI
|
13
|
Lindmark G, Sundberg C, Glimelius B,
Påhlman L, Rubin K and Gerdin B: Stromal expression of
platelet-derived growth factor beta-receptor and platelet-derived
growth factor B-chain in colorectal cancer. Lab Invest. 69:682–689.
1993.PubMed/NCBI
|
14
|
Shao ZM, Nguyen M and Barsky SH: Human
breast carcinoma desmoplasia is PDGF initiated. Oncogene.
19:4337–4345. 2000. View Article : Google Scholar : PubMed/NCBI
|
15
|
Betsholtz C, Karlsson L and Lindahl P:
Developmental roles of platelet-derived growth factors. Bioessays.
23:494–507. 2001. View Article : Google Scholar : PubMed/NCBI
|
16
|
Chen YQ, Ni DJ, Cheng Q, Hung HB, Meng Y
and Wu MC: Study on the hypolipidemic effect of flavones and
dihydromyricetin From Tengcha. J Tea Sci. 3:221–225, 242. 2007.
|
17
|
Zhong ZX, Zhou GF, Chen XF and Qin JP:
Experimental study on the protective effect of dihydromyricetin
from Guangxi Ampelopsis grossepentata on liver. Chin J Tradit Med
Sci Technol. 9:155–156. 2002.
|
18
|
Xu JJ, Yao MJ and Wu MC: Study on
biological efficacy of dihydromyricetin. Food Sci. 29:622–625.
2008.
|
19
|
Shen Y, Lindemeyer AK, Gonzalez C, Shao
XM, Spigelman I, Olsen RW and Liang J: Dihydromyricetin as a novel
anti-alcohol intoxication medication. J Neurosci. 32:390–401. 2012.
View Article : Google Scholar : PubMed/NCBI
|
20
|
He GX, Yang WL, Pei G, Zhu YH and Du FL:
Studies on the effect of dihydromyricetin on
antilipid-peroxidation. Zhongguo Zhong Yao Za Zhi. 28:1188–1190.
2003.PubMed/NCBI
|
21
|
Mueller L, Goumas FA, Himpel S, Brilloff
S, Rogiers X and Broering DC: Imatinib mesylate inhibits
proliferation and modulates cytokine expression of human
cancer-associated stromal fibroblasts from colorectal metastases.
Cancer Lett. 250:329–338. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Gioni V, Karampinas T, Voutsinas G,
Roussidis AE, Papadopoulos S, Karamanos NK and Kletsas D: Imatinib
mesylate inhibits proliferation and exerts an antifibrotic effect
in human breast stroma fibroblasts. Mol Cancer Res. 6:706–714.
2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Pietras K, Pahler J, Bergers G and Hanahan
D: Functions of paracrine PDGF signaling in the proangiogenic tumor
stroma revealed by pharmacological targeting. PLoS Med. 5:e192008.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Micke P and Ostman A: Tumour-stroma
interaction: Cancerassociated fibroblasts as novel targets in
anti-cancer therapy? Lung Cancer. 45(Suppl 2): S163–S175. 2004.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Kitadai Y, Sasaki T, Kuwai T, Nakamura T,
Bucana CD, Hamilton SR and Fidler IJ: Expression of activated
platelet-derived growth factor receptor in stromal cells of human
colon carcinomas is associated with metastatic potential. Int J
Cancer. 119:2567–2574. 2006. View Article : Google Scholar : PubMed/NCBI
|
26
|
Tejada MLI, Yu L, Dong J, Jung K, Meng G,
Peale FV, Frantz GD, Hall L, Liang X, Gerber HP and Ferrara N:
Tumor-driven paracrine platelet-derived growth factor receptor
alpha signaling is a key determinant of stromal cell recruitment in
a model of human lung carcinoma. Clin Cancer Res. 12:2676–2688.
2006. View Article : Google Scholar : PubMed/NCBI
|